RA is opening my eyes to the complex world of high level, biological medicines. According to one source, the global market for TNF inhibitors (e.g. Enbrel, Humira, etc.) was $13.5 billion in 2008. Understandably, it takes years of research, clinical trials, and approval processes in multiple countries before a new medication hits the market. And recouping those costs is important since the pharmaceutical companies have so much invested. But these dollar amounts amaze me when I consider the exorbitant retail price (about $1,800 a month) and the fact that the FDA gives a 14 year lock on biologicals before making it generic (7 years for other drugs).
Please consider making a donation to Rheumatoid Arthritis Guy.
- Canyons, Bridges, And WavesAugust 27, 2014 - 8:23 am
- I Thank My Rheumatoid Arthritis For…May 25, 2014 - 1:07 pm
- Visual Journal: My StoryDecember 18, 2013 - 12:31 am
- FreefallDecember 11, 2013 - 11:46 am
- My Decision To Not Use Medicines Right Now Is All About Personal ResponsibilityNovember 6, 2013 - 11:13 am
- Arthritis Broadcast Network: Spotlight On Arthritis SuperheroesSeptember 10, 2014 - 7:34 pm
- The New York Times: Actress, Artist, Sometimes Both At OnceMay 20, 2014 - 10:29 am
- The Columbian: Arthritis Not stopping 20-Year-Old Nursing StudentApril 15, 2014 - 3:25 pm
- Name My Cane!November 9, 2013 - 11:51 pm
- StælkenNovember 4, 2013 - 1:57 pm